Health Sciences Acquisitions Corp 2 HSAQ
We take great care to ensure that the data presented and summarized in this overview for Health Sciences Acquisitions Corp 2 is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HSAQ
View allLatest Institutional Activity in HSAQ
Top Purchases
Top Sells
About HSAQ
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.
Insider Transactions at HSAQ
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2025
|
Eric S Fain Director |
SELL
Open market or private sale
|
Indirect |
2,683
-5.0%
|
$8,049
$3.05 P/Share
|
|
Jun 24
2025
|
Jason Aryeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,422
+11.84%
|
-
|
|
Jun 24
2025
|
Chris Cleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,422
+35.49%
|
-
|
|
Jun 24
2025
|
Eric S Fain Director |
BUY
Grant, award, or other acquisition
|
Indirect |
12,422
+18.81%
|
-
|
|
Jun 24
2025
|
Connealy Pamela Yanchik Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,422
+26.93%
|
-
|
|
Jun 24
2025
|
John Prosper Mack Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,422
+32.94%
|
-
|
|
Jun 24
2025
|
David Pacitti Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,422
+29.3%
|
-
|
|
Jun 18
2025
|
Joshua Aiello Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-8.32%
|
$786
$2.99 P/Share
|
|
Jun 11
2025
|
David P Hochman Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
5,671
-1.69%
|
$17,013
$3.14 P/Share
|
|
Jun 11
2025
|
David P Hochman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
34,038
-5.87%
|
$102,114
$3.14 P/Share
|
|
Jun 11
2025
|
Andrew Lawrence Taylor Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,172
-6.57%
|
$84,516
$3.14 P/Share
|
|
May 28
2025
|
Darren Sherman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
45,843
-5.4%
|
$91,686
$2.95 P/Share
|
|
Apr 30
2025
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
49,900
+0.6%
|
$99,800
$2.99 P/Share
|
|
Apr 29
2025
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+0.6%
|
$100,000
$2.53 P/Share
|
|
Apr 04
2025
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
98,333
+14.51%
|
-
|
|
Apr 04
2025
|
Andrew Lawrence Taylor Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84,000
+16.38%
|
-
|
|
Apr 04
2025
|
Darren Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
115,708
+11.99%
|
-
|
|
Mar 26
2025
|
Joshua Aiello Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-5.56%
|
$1,112
$4.38 P/Share
|
|
Mar 07
2025
|
David P Hochman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
80,080
-13.82%
|
$320,320
$4.23 P/Share
|
|
Feb 03
2025
|
Chris Cleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,155
+50.0%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 396K shares |
|---|---|
| Open market or private purchase | 122K shares |
| Exercise of conversion of derivative security | 11.7K shares |
| Open market or private sale | 42.6K shares |
|---|---|
| Payment of exercise price or tax liability | 261K shares |
| Other acquisition or disposition | 3.41M shares |